{"id":"W2520697216","doi":"","title":"Randomized phase 3 trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU) - GRID trial","year":2012,"lang":"en","type":"article","venue":"Data Archiving and Networked Services (DANS)","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Regorafenib; Sunitinib; GiST; Medicine; Imatinib; Internal medicine; Oncology; Sunitinib malate; Stromal tumor; Randomized controlled trial; Stromal cell; Colorectal cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001084712,0.0004945393,0.001271152,0.0002035641,0.0002687924,0.0001181115,0.0002005651,0.00001908535,0.00001604156],"category_scores_gemma":[0.0001395626,0.0002778428,0.00005652995,0.0002510282,0.000545294,0.0004345339,0.0003205926,0.0002468013,8.583374e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008632807,"about_ca_system_score_gemma":0.0001688084,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000683167,"about_ca_topic_score_gemma":0.0009047007,"domain_scores_codex":[0.9966239,0.0006248202,0.0006970642,0.0006330256,0.0005388204,0.0008823733],"domain_scores_gemma":[0.997299,0.0009908261,0.0004683368,0.0005708455,0.0000783502,0.0005926116],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8693894,0.002920859,0.1196877,0.0005521754,0.0002540608,0.0002922988,0.000814834,0.000007308604,0.00008296307,0.000005032027,0.000004318352,0.005989057],"study_design_scores_gemma":[0.9348962,0.03456201,0.01344766,0.003219441,0.0008527144,0.00143568,0.0006676581,0.01056782,0.00006374393,0.000005245728,0.00003236837,0.0002494687],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948643,0.0003338868,0.0001420485,0.00004996036,0.00003315586,0.004073128,0.0003932694,0.000036951,0.00007326349],"genre_scores_gemma":[0.9776795,0.00005943173,0.02017338,0.0000131278,0.0001963035,0.0002057559,0.001567963,0.00005174951,0.00005280874],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.10624,"threshold_uncertainty_score":0.9999674,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04755688638292465,"score_gpt":0.3274462579719044,"score_spread":0.2798893715889797,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}